REVIEW Triphenyl valsartan is an advanced intermediate towards the preparation of valsartan, an angiotension II receptor antagonist, used in the treatment of hypertension.
REFERENCES
[1]
Buhlmayer, Peter. Preparation of N-aryl amino acid carboxyalkyl ester derivatives as angiotensin II antagonists PCT Int. Appl. (1997), WO 9730036 A1 19970821.
[2]
Cordi, Alexis; Haberkorn, Laure; Verbeuren, Tony; Courchay, Christine; Simonet, Serge; New diazenium diolate derivatives, their preparation process, and the pharmaceutical compositions which contain them. Fr. Demande (2007), FR 2902428 A1 20071221.
[3]
Preparation of (S)-N-(1-carboxy-2-methyl-prop-1-YL)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]amine IP.com Journal (2009), 9(5B), 47.
[4]
Dallatomasina, Franco; Guandalini, Luca; Martini, Elisabetta; Romanelli, Maria Novella; Method for deprotecting N-protected tetrazole derivatives Ital. Appl. (2006), IT 2006TO0380 A1 20060825.
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. CATEGORIES APIs and Bioactives > Angiotensin Receptor Blockers
Add to Favorites 
Delete from Favorites 
